IDH1 and acute myeloid leukemia: We observed that IDH1/2 LNA-qPCR MRD elevations preceded frank hematological relapse and confirmed that IDH1/2 LNA-qPCR MRD after induction therapy and during consolidation could predict relapse in AML patients but did not significantly predict OS.